NasdaqGS:HOLXMedical Equipment
Hologic (NasdaqGS:HOLX) Expands Global Reach With CE-Marked Affirm Contrast Biopsy Software
Hologic (NasdaqGS:HOLX) recently announced the CE-marking of its Affirm Contrast Biopsy Software, enhancing its breast imaging portfolio with advanced diagnostic capabilities. Concurrently, the company's Aptima SARS-CoV-2 assay gained 510(k) FDA clearance, solidifying its commitment to respiratory diagnostics. Over the last week, Hologic's share price saw a modest increase of 1.1%. This price movement occurred amidst a backdrop of downward pressures in major markets, with the Dow Jones, S&P...